Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M73,068Revenue $M20,247Net Margin (%)20.2Altman Z-Score3.9
Enterprise Value $M72,236EPS $1.5Operating Margin %14.1Piotroski F-Score6
P/E(ttm)17.9Beneish M-Score-2.6Pre-tax Margin (%)14.0Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %0.2Quick Ratio1.9Cash flow > EarningsN
Price/Sales3.75-y EBITDA Growth Rate %-16.2Current Ratio2.2Lower Leverage y-yN
Price/Free Cash Flow32.9y-y EBITDA Growth Rate %11.0ROA % (ttm)10.0Higher Current Ratio y-yY
Dividend Yield %1.9PEG--ROE % (ttm)18.5Less Shares Outstanding y-yY
Payout Ratio %67.0Shares Outstanding M1,489ROIC % (ttm)8.6Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTMason Hawkins 2015-03-31 Sold Out -2.3%$43.41 - $47.83
($45.92)
$ 49.418%Sold Out0
ABTFirst Eagle Investment 2015-03-31 Add0.43%$43.41 - $47.83
($45.92)
$ 49.418%Add 311.11%5,142,802
ABTRichard Pzena 2015-03-31 Reduce-0.12%$43.41 - $47.83
($45.92)
$ 49.418%Reduce 7.09%6,373,745
ABTJoel Greenblatt 2015-03-31 Buy 0.01%$43.41 - $47.83
($45.92)
$ 49.418%New holding41,573
ABTKen Fisher 2015-03-31 Reduce$43.41 - $47.83
($45.92)
$ 49.418%Reduce 5.30%13,095
ABTMario Gabelli 2015-03-31 Reduce$43.41 - $47.83
($45.92)
$ 49.418%Reduce 0.08%65,287
ABTDodge & Cox 2015-03-31 Reduce$43.41 - $47.83
($45.92)
$ 49.418%Reduce 13.49%32,068
ABTMason Hawkins 2014-12-31 Reduce-0.79%$39.99 - $46.37
($43.58)
$ 49.4113%Reduce 28.08%8,977,941
ABTGeorge Soros 2014-12-31 Reduce-0.06%$39.99 - $46.37
($43.62)
$ 49.4113%Reduce 24.46%602,181
ABTMario Gabelli 2014-12-31 Reduce-0.01%$39.99 - $46.37
($43.58)
$ 49.4113%Reduce 33.96%65,337
ABTKen Fisher 2014-12-31 Add$39.99 - $46.37
($43.58)
$ 49.4113%Add 22.80%13,828
ABTMason Hawkins 2014-09-30 Reduce-0.26%$41.05 - $43.69
($42.33)
$ 49.4117%Reduce 8.80%12,483,566
ABTMario Gabelli 2014-09-30 Reduce-0.01%$41.05 - $43.69
($42.33)
$ 49.4117%Reduce 38.44%98,937
ABTKen Fisher 2014-09-30 Reduce$41.05 - $43.69
($42.33)
$ 49.4117%Reduce 37.53%11,261
ABTFirst Eagle Investment 2014-06-30 Buy 0.16%$37.02 - $41
($39.24)
$ 49.4126%New holding1,665,688
ABTGeorge Soros 2014-06-30 Reduce-0.11%$37.02 - $41
($39.24)
$ 49.4126%Reduce 23.73%932,181
ABTKen Fisher 2014-06-30 Add$37.02 - $41
($39.24)
$ 49.4126%Add 106.12%18,027
ABTRichard Pzena 2014-03-31 Add0.11%$35.85 - $40.12
($38.5)
$ 49.4128%Add 7.90%6,934,282
ABTGeorge Soros 2014-03-31 Add0.1%$35.85 - $40.12
($38.54)
$ 49.4128%Add 25.97%1,222,181
ABTRobert Olstein 2013-12-31 Add0.19%$33.01 - $38.71
($36.89)
$ 49.4134%Add 23.45%179,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pavee Jean-YvesSenior Vice President 2015-06-03Sell10,500$490.84view
Mason Heather LExecutive Vice President 2015-04-27Sell13,500$47.454.13view
BIRD ROGERSenior Vice President 2015-04-27Sell28,548$47.573.87view
Contreras JaimeSenior Vice President 2015-03-31Sell228$46.436.42view
White J. ScottSenior Vice President 2015-03-26Sell12,483$46.685.85view
Warmuth Michael JExecutive Vice President 2015-03-10Sell13,500$46.416.46view
Pavee Jean-YvesSenior Vice President 2015-03-02Sell652$47.484.06view
Contreras JaimeSenior Vice President 2015-03-02Sell9,209$47.344.37view
Contreras JaimeSenior Vice President 2015-02-18Sell423$46.266.81view
Pavee Jean-YvesSenior Vice President 2015-02-17Sell621$46.416.46view

Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    Mason Hawkins Comments on Abbott Laboratories May 28 2015 
    Endo International Posts Upbeat Q1 Results May 13 2015 
    How Much Money Will You Need To Retire? Mar 31 2015 
    Top Stock Picks Among Companies That Recently Increased Dividends Mar 09 2015 
    Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 
    AbbVie’s Q4 Reflects Its Tremendous Growth Potential Going Forward Feb 04 2015 
    What Could Be The Major Highlights In AbbVie’s Upcoming Earnings Call? Jan 29 2015 
    Feeling Good With This Med Company Jan 20 2015 
    Diamond Hill Adds Two Companies to Portfolio in Third Quarter Dec 11 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 

    More From Other Websites
    These stocks win in 2nd half Jul 01 2015
    Abbott Hosts Conference Call for Second-Quarter Earnings Jul 01 2015
    Intercept Pharmaceuticals Files for OCA in U.S. and Europe - Analyst Blog Jun 30 2015
    Activist investors love spin-offs. Here’s why you should, too Jun 29 2015
    Easier Blood-Sugar Monitoring for Diabetics Jun 28 2015
    5 Trade Ideas for Monday: Abbott Labs, Cognex, Lazard, Northern Trust & Tractor Supply Jun 28 2015
    3 Healthcare Stocks For A Growing Global Middle Class Jun 22 2015
    Mylan Inks Deal with Pulmatrix for Respiratory Disease Drug - Analyst Blog Jun 17 2015
    Abbott Backs Mylan and Its Strategy to Buy Perrigo Jun 16 2015
    Big shareholder backs drugmaker Mylan's growth strategy Jun 16 2015
    Big shareholder backs drugmaker Mylan's growth strategy Jun 16 2015
    Stocks End Near Highs; Perrigo Rebounds On Mylan Deal Jun 16 2015
    Deal talk drives US stocks to modest gains Jun 16 2015
    Deal talk drives US stocks to modest gains Jun 16 2015
    How An Inversion Is Paying Off Twice In Mylan's Fight Against Teva Pharmaceutical Jun 16 2015
    Mylan's largest shareholder Abbott Laboratories backs in Perrigo bid Jun 16 2015
    Abbott to Vote in Favor of Mylan's Perrigo Deal Jun 16 2015
    Abbott to vote for Mylan's acquisition of Perrigo Jun 16 2015
    Mylan Issues Statement in Response to Abbott's Support for Perrigo Transaction Jun 16 2015
    Abbott Will Back Mylan’s Perrigo Bid Using 14.5% Share Stake Jun 16 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK